AVODART (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the AVODART drug offered from GlaxoSmithKline LLC. This 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | dutasteride |
SUBSTANCE NAME: | DUTASTERIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, LIQUID FILLED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-12-10 |
END MARKETING DATE: | 0000-00-00 |
AVODART HUMAN PRESCRIPTION DRUG Details:
Item Description | AVODART from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2002-12-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0712_ce45b582-6189-4d16-a003-af3127c7c75f |
PRODUCT NDC: | 0173-0712 |
APPLICATION NUMBER: | NDA021319 |
Other DUTASTERIDE Pharmaceutical Manufacturers / Labelers: